tldrdailynews.com logo
Tag

Pharmaceutical Industry

All articles tagged with #pharmaceutical industry

Eric Cantor to Lead PhRMA as Pharma Faces Pricing and AI Scrutiny
politics10 days ago

Eric Cantor to Lead PhRMA as Pharma Faces Pricing and AI Scrutiny

Former House Majority Leader Eric Cantor has been appointed president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), effective November 9. He will succeed Steve Ubl, who is stepping down after 11 years. Cantor, a former Virginia Republican and current Moelis & Company executive, will lead the industry’s top lobbying group amid intense scrutiny over drug pricing, AI integration, and regulatory changes.

via Axios|
#drug-pricing#eric-cantor#pharmaceutical-industry
Trump expands voluntary drug-price deals with nine more manufacturers
politics1 month ago

Trump expands voluntary drug-price deals with nine more manufacturers

President Trump announced a new round of voluntary drug-pricing agreements with nine manufacturers, bringing the total to 26 deals since the program began. The pledges include pricing drugs near the lowest international rates, applying most-favored-nation terms to Medicaid, and, in some cases, boosting domestic manufacturing and stockpiles. Details are not publicly released, and the overall impact on costs remains unclear.

via STAT|
#drug-pricing#healthcare-policy#medicaid
BMS Shares Jump on Reported AstraZeneca Tie-Up Worth About $400 Billion
business2 months ago

BMS Shares Jump on Reported AstraZeneca Tie-Up Worth About $400 Billion

Bristol Myers Squibb stock rose about 4% premarket after a Financial Times report that BMS and AstraZeneca discussed a potential $400 billion merger, while AstraZeneca ADRs fell. The deal would be one of the largest in pharma history and comes as 2026 sees a wave of big M&A activity, though analysts warned mega-deals can slow R&D productivity and pipeline progress.

via Barron's|
#astrazeneca#bristol-myers-squibb#business
Generic-Drug Tariffs Put U.S. Drug Onshoring to the Test
business2 months ago

Generic-Drug Tariffs Put U.S. Drug Onshoring to the Test

Trump’s proposal would slap tariffs on imported generic medicines with two years of no duties, then 100% for a year and 200% thereafter, to spur U.S. manufacturing. Industry warns the move could raise prices or force manufacturers to absorb costs, shift production, or exit markets, and that meaningful onshoring faces four-to-five-year timelines. Impacts will vary by company based on existing U.S. footprint and product mix, and much hinges on policy specifics like whether tariffs apply to finished drugs or imported active ingredients and how “domestic manufacturing” is defined.

via CNBC|
#business#generic-drugs#pharmaceutical-industry
Lilly bets $4B on infectious-disease push with three acquisitions
business4 months ago

Lilly bets $4B on infectious-disease push with three acquisitions

Eli Lilly said it will buy Curevo, LimmaTech Biologics and The Vaccine Company for almost $4 billion in cash to expand infectious-disease R&D, sending its shares higher in premarket trading. Curevo develops a shingles vaccine, LimmaTech targets resistant bacterial pathogens including STIs, and The Vaccine Company advances in vivo nanoparticle delivery technologies for drugs, genes, and diagnostics. The move comes as Lilly relies on Zepbound and Mounjaro for strong revenue and introduces Foundayo to compete with Novo Nordisk in obesity treatments.

via CNBC|
#acquisitions#business#eli-lilly
Trump’s Drug-Pricing Push Delivers Some Discounts, But Prices Climb for Many
healthcare5 months ago

Trump’s Drug-Pricing Push Delivers Some Discounts, But Prices Climb for Many

Trump’s drug-pricing efforts have yielded uneven gains: Medicare's negotiated discounts cut some prices and cap out-of-pocket costs, and TrumpRx offered notable cuts on certain brand drugs, but overall about 1,000 branded drugs rose in price in early 2026, and benefits mostly reach cash-paying patients, with many discounts opaque and limited in scope; experts say the policy changes do not broadly reshape drug pricing.

via CBS News|
#biosimilars#drug-prices#healthcare
Big Pharma to Raise Prices on 350 Medications Despite Political Pressure
business9 months ago

Big Pharma to Raise Prices on 350 Medications Despite Political Pressure

Drugmakers plan to raise prices on at least 350 medicines in the US for 2026, including vaccines and cancer treatments, despite pressure from the Trump administration to lower costs. While some drugs will see price cuts, overall prices are increasing, with companies like Pfizer and GSK citing the need to support innovation and cover costs. These hikes occur even as the US continues to pay significantly more for prescription drugs compared to other developed nations.

via CNN|
#business#drug-prices#medicare
FDA Grants First Priority Review Vouchers to Nine Drugs
health11 months ago

FDA Grants First Priority Review Vouchers to Nine Drugs

The FDA announced the first nine recipients of the Commissioner’s National Priority Review vouchers, which expedite drug reviews for products aligned with national health priorities. Notably, EMD Serono received a voucher after agreeing to lower prices for its fertility drugs, including Pergoveris, in a move highlighted by President Trump. The program aims to incentivize companies to develop and provide access to important medications.

via statnews.com|
#drug-approval#emd-serono#fda
U.S. Imposes Tariffs on Drugs, Furniture, and Lumber Amid Trade Tensions
business1 year ago

U.S. Imposes Tariffs on Drugs, Furniture, and Lumber Amid Trade Tensions

Drug stocks are rallying as President Trump's proposed 100% tariff on branded pharmaceutical imports mainly affects companies without U.S. manufacturing, leaving most Big Pharma and generics unaffected. The tariffs highlight supply chain vulnerabilities and long-term national security concerns, especially dependence on foreign countries like China for generics, but could also hinder biotech innovation and complicate import processes.

via Investor's Business Daily|
#business#drug-stocks#generic-drugs